AF

Anthony P. Ford

AP Afferent Pharmaceuticals: 12 patents #1 of 9Top 15%
RA Roche Palo Alto: 3 patents #128 of 347Top 40%
S( Syntex (U.S.A.): 3 patents #196 of 599Top 35%
Merck: 1 patents #5,419 of 9,382Top 60%
📍 Palo Alto, CA: #1,067 of 9,675 inventorsTop 15%
🗺 California: #24,270 of 386,348 inventorsTop 7%
Overall (All Time): #181,654 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
11607395 Methods for improving neurological diseases and disorders Gabriel Vargas 2023-03-21
11590107 Methods for treating neurological disorders with α1A-AR partial agonists 2023-02-28
11591315 Substituted pyrazole-pyrimidines, variants thereof, and uses therefore Ronald Charles Hawley, Prabha N. Ibrahim, Joel R. Gever 2023-02-28
11260056 Diaminopyrimidine P2X3 and P2X2/3 receptor modulators for use in the treatment of cough Kathleen Sereda Glaub, Michael M. Kitt, Steven A. Smith 2022-03-01
11230533 Crystalline salts and polymorphs of a P2X3 antagonist Prabha N. Ibrahim, Ronald Charles Hawley, Steven A. Smith 2022-01-25
11230532 Pyrimidines and variants thereof, and uses therefor Ronald Charles Hawley, Prabha N. Ibrahim, Joel R. Gever 2022-01-25
11040944 Beta adrenergic agonist and methods of using the same Wei Chen, David Scott Carter, Jiaxin Yu 2021-06-22
10988460 Substituted pyrazole-pyrimidines, variants thereof, and uses therefore Ronald Charles Hawley, Prabha N. Ibrahim, Joel R. Gever 2021-04-27
10947196 Beta adrenergic agonist and methods of using the same Wei Chen, David Scott Carter, Jiaxin Yu 2021-03-16
10822311 Pyrimidines and variants thereof, and uses therefor Ronald Charles Hawley, Prabha N. Ibrahim, Joel R. Gever 2020-11-03
10676444 Crystalline salts and polymorphs of a P2X3 antagonist Prabha N. Ibrahim, Ronald Charles Hawley, Steven A. Smith 2020-06-09
10662162 Pyrimidines and variants thereof, and uses therefor Ronald Charles Hawley, Prabha N. Ibrahim, Joel R. Gever 2020-05-26
10543211 Methods and compositions for treating diseases and conditions Julian Paton 2020-01-28
10206922 Substituted pyrimidines for treatment of chronic cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough Bruce G. McCarthy 2019-02-19
10195198 Methods and compositions for treating diseases and conditions Julian Paton 2019-02-05
9724346 Substituted pyrimidines for treatment of a cough selected from chronic pathological cough, sub-acute pathological cough, acute pathological cough, neuronal hypersensitivity underlying chronic cough, neuronal hypersensitivity underlying sub-acute cough and neuronal hypersensitivity underlying acute cough Bruce G. McCarthy 2017-08-08
9284279 Substituted pyrimidines for treatment of acute cough, chronic cough and urge to cough Bruce G. McCarthy 2016-03-15
8524725 Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modulators for treatment of respiratory and gastrointestinal diseases Chris Allen Broka, David Scott Carter, Michael Patrick Dillon, Ronald Charles Hawley, Alam Jahangir +2 more 2013-09-03
8008313 Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases Chris Allen Broka, David Scott Carter, Michael Patrick Dillon, Ronald Charles Hawley, Alam Jahangir +2 more 2011-08-30
7531529 Imidazole derivatives Bernd Buettelmann, Simona M. Ceccarelli, Georg Jaeschke, Sabine Kolczewski, Richard Hugh Philip Porter +2 more 2009-05-12
6733982 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity Timothy J. Williams, Kathleen Ruth Gogas, Lupita O. Jacobson 2004-05-11
6515198 Use of purinergic receptor modulators and related reagents Debra Cockayne, Quan-Ming Zhu, Wilhelm Lachnit, Annika Malmberg 2003-02-04
6355641 Oxazolone derivatives and uses thereof David L. Coffen, Michael Patrick Dillon, Zhe Li, Timothy J. Williams 2002-03-12